openPR Logo
Press release

Mersana Teams Up with Mystic’s Document Control Software

09-04-2009 06:27 PM CET | IT, New Media & Software

Press release from: Mystic Management Systems, Inc.

Mersana Teams Up with Mystic’s Document Control Software

Mystic Management Systems' ensur Document Control Software identified as Mersana Therapeutic's newest member of their Quality Department.

Norwich, CT – Mystic Management Systems’ document control software product ensur was selected by Mersana Therapeutics, Inc. of Cambridge, Massachusetts, for document and version control of their key quality content. Mersana’s ensur deployment will be in conjunction with the introduction of a second lead product candidate.

“Mersana’s progress in the cancer therapeutics division is globally recognized and being partnered with them in their future success is a tremendous opportunity “said Erica Sullivan-Corbett of Mystic Management Systems, Inc.

The deployment of ensur at Mersana will be validated in line with the FDA’s 21CFR Part 11 regulations and will include the installation of the latest 4.0 version of Document Control, Change Control, CAPA, TMS, Quiz Builder, Form Builder, Quality Binder, Bills of Material, Publish, Mail, Reports, Controlled Printing and Watermarking.

About Mersana Therapeutics, Inc.

Named after the Russian goddess of harvest, Mersana’s strategy is to identify promising cancer agents that faltered in development despite evidence of clinical efficacy and to bring them to fruition.

Mersana, a privately held, venture backed company, utilizes its proprietary nanotechnology platform to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties. The key component of Mersana’s platform is Fleximer®, a novel, biodegradable and bio-inert polymer that can be chemically linked to small molecules and biologics. Mersana’s pipeline includes XMT-1001, a Fleximer-camptothecin conjugate which is currently in Phase 1 clinical trials, and several preclinical oncology compounds. Mersana’s investors include Fidelity Biosciences, ProQuest Investments, Rho Ventures, Harris & Harris Group and PureTech Ventures.

About Mystic Management Systems, Inc.

Mystic Management Systems, Inc. is a twenty-five year old leading global provider of quality software solutions, including document control software, product lifecycle management, product and packaging/specification management, as well as corrective and preventative action. Using applications from Mystic Management Systems, companies throughout the world have been improving profits, reducing costs, and producing better quality products since 1983.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to Mystic Management Systems, Inc. are intended to identify such forward-looking statements. MMS undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations.

Copyright © 2009 Mystic Management Systems, Inc. All rights reserved.
For companies interested in learning more about MMS products:
Worldwide: (01) 860-887-2900
www.mysticmsi.com
info@mysticmsi.com

Mystic Management Systems, Inc.
190 West Town Street
Norwich, CT 06360
Erica Sullivan-Corbett
ecorbett@mysticmsi.com
860-887-2900

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mersana Teams Up with Mystic’s Document Control Software here

News-ID: 94348 • Views:

More Releases from Mystic Management Systems, Inc.

ensur Document Control Software Expands South of the Border
Mystic Management Systems' ensur Document Control Software expands within Wyeth Nutritionals to Mexico City Norwich, CT – The relationship between Wyeth Nutrition and Mystic Management Systems’ document control software product has experienced another growth spurt. What once started as a single site partnership with Wyeth in Vermont has grown to include Pennsylvania, The United Kingdom, Ireland, Singapore, The Philippines, China, and now Mexico. Even as the state of the economy has
Leader in Touch Screen Console Systems Chooses ensur for Document and Version Control
Leader in Touch Screen Console Systems Chooses ensur for Document and Version Co …
Leading supplier of touch screen console systems selects Mystic Management Systems’ software product ensur for document control and version control for 25,000+ documents. Avtec will have access to the full suite of ensur modules. Norwich, CT – Mystic Management Systems’ quality management software product ensur was selected by Avtec, Inc. of Gilbert, South Carolina, for document control and version control of Avtec’s key manufacturing and product documentation. Avtec’s deployment
Mystic Management Systems Releases ensur 4.0
Mystic Management Systems Releases ensur 4.0
Mystic Management Systems builds more functionality in its web based Quality Management System granting more freedom with more control. Norwich, CT – Mystic Management Systems, Inc., a leading provider of quality management software solutions for over twenty-five years, releases its latest version of ensur. The ensur Quality Management System is a web based application that can be deployed in small starting businesses as well as an enterprise wide solution.
Transitions Optical Inc. Purchases the ensur Quality Management System
Transitions Optical Inc. Purchases the ensur Quality Management System
Norwich, CT – Mystic Management Systems, Inc. a twenty-five year supplier of quality management software to the life sciences, manufacturing, and packaged goods industries has been selected by Transitions Optical, Inc. of Pinellas Park, Florida. Mystic Management Systems will deploy the ensur Quality Management System, which contains document control, corrective action preventive action, and employee training management solutions. “Transitions Optical, Inc. was meticulous in their selection of a quality

All 5 Releases


More Releases for Mersana

Antibody Drug Conjugate Market 2021 (impact of COVID-19) Trend, Future Scope, Gr …
A report was released recently that sheds lots of light on the Antibody Drug Conjugate Industry. The report covers an overview of the industry along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very
Antibody Drug Conjugate Market, Top key players are Roche, ImmunoGen, Immunomedi …
Antibody Drug Conjugate Market Size, Status and Forecast 2026 The Antibody Drug Conjugate Market Research Report is a valuable source of insightful data for business strategists. It provides the Antibody Drug Conjugate Market industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antibody Drug Conjugate study provides
Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market Res …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on “Global Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market Assessment – Revenue (US$ Mn) Forecast Till 2028” Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-antibody-drug-conjugates-adcs-linker-and-conjugation-technologies-market-assessment/ Antibody Drug Conjugates (ADCs) characterize a promising and a competent approach for targeted cancer therapy. The type of antibody used to generate the drug is selected based upon unique biomarkers found on the cancer cells
Antibody Drug Conjugate Market By Size, Trends and Industry Analysis 2026| Roche …
Latest Report On Antibody Drug Conjugate Market including Market Landscape, and Market size, Revenues by players, Revenues by regions, Average prices, Competitive landscape, market Dynamics and industry trends and developments during the forecast period. The global Antibody Drug Conjugate market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly
Antibody Drug Conjugate Market Massive Growth and Demand with Top Key Players: R …
A report added to the rich database of Qurate Business Intelligence, titled “Antibody Drug Conjugate Market - Global Industry Analysis and Forecast to 2023”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data
Antibody Drug Conjugate (ADC) Market Analysis 2019-2023 and Demand Estimated at …
The report offer complete coverage on industry situations, growth, and demands, industry drivers, restraints, business strategies utilized. Additionally, competitive analysis by Antibody Drug Conjugate Market players, opportunities, future roadmap, and major vendor profiles has been presented in the report. Market Analysis The global antibody drug conjugate (ADC) market is projected to witness a stupendous growth at a notable 19% CAGR over the predicted years (2017-2023). ADCs are made of three parts- first